Latest Documents


  • 22-March-2018

    English

    Economic assessment and valuations of environmental and health impacts caused by Perfluorooctanoic acid (PFOA) and its salts - Environment Working Paper

    Perfluorooctanoic acid (PFOA) is being used in fluoropolymer production, as surface treatment agents and for the manufacture of side-chain fluorinated polymers. However, there is evidence that PFOA and its salts have a number of hazardous properties that may cause harm to human health and the environment. This report evaluates existing economic assessments and valuations of impacts arising from PFOA and its salts.

  • 8-March-2018

    English

    Adverse Outcome Pathways, Molecular Screening and Toxicogenomics

    AOP-Wiki version 2.2 contains a large number of new features including multiple navigational tips, the redesign of the AOP pages, the update of the snapshot format to match the new AOP Users' handbook and a new format (AOP-XML) allowing the users to obtain all AOP-Wiki content in an easily usable form. AOP-Wiki users are encouraged to follow our new AOP Users' Handbook providing practical instructions on AOP development.

    Related Documents
  • 23-February-2018

    English

    OECD Good Laboratory Practice: Frequently asked questions (FAQ)

    GLP issues raised by testing labs are covered in this comprehensive list of questions and answers, recently updated with questions related to: sponsors, Contract Research Organisations (CROs), sub-contractors, archives, Information Technology (IT), Biotechnology/GMOs and other miscellaneous issues

    Related Documents
  • 28-January-2018

    English

    Draft Guidance and Review Documents/Monographs

    Deadline for comments: Draft Guidance Document on Aquatic and Sediment Toxicological Testing of Nanomaterials by 30 October 2018.

    Related Documents
  • 3-January-2018

    English

    Exposure Assessment

    Risks to human health and the environment posed by chemicals is determined by the chemical-specific hazard properties and the extent of exposure to chemicals. Read more on the OECD work in developing and harmonising methods for assessing the exposure of chemicals to humans and the environment.

    Related Documents
  • 21-December-2017

    English

    Safety Assessment of Transgenic Organisms in the Environment, Volume 7 - OECD Consensus Documents

    Volume 7 of the Series compiles the OECD consensus documents for use in environmental risk assessment of transgenic organisms (biosafety) issued in 2016 and 2017.The first two chapters cover the biology of plant species (sorghum and tomato) and include elements of taxonomy, centres of origin, reproductive biology, genetics, outcrossing, crop production and cultivation practices, interactions with other organisms, main pests and pathogens, and biotechnological developments.The third chapter relates to Atlantic salmon, the first OECD biosafety publication to address an animal species. It describes the biology and ecology of wild salmon (including classification, life stages, reproduction, centres of origin, geographical distribution, population dynamics, interaction with other organisms) and of the farmed form (domestication, aquaculture rearing practices, biocontainment, interactions with the external environment). It also provides elements of genetics, research on genetically engineered salmon and resources for its risk assessment.
  • 6-December-2017

    English

    BioTrack Product Database

    This OECD database allows regulatory officials and stakeholders to share information on products derived from the use of modern biotechnology, as well as some products with novel traits acquired by the use of conventional breeding or mutagenesis, that have been approved for commercial application in at least one country, in terms of food, feed or environmental safety.

    Related Documents
  • 4-December-2017

    English

    Environmental biosafety

    Most OECD countries and many non-members have a system of regulatory oversight for products of modern biotechnology (genetically-engineered /transgenic organisms) which are intended for release to the environment. The OECD biosafety work programme aims to consider all types of organisms (plants, trees, animals, micro-organisms) and to promote international harmonisation.

    Related Documents
  • 24-November-2017

    English

    eChemPortal: Global Portal to Information on Chemical Substances

    The National Industrial Chemicals Notification and Assessment Scheme's (NICNAS) established the Inventory Multi-tiered Assessment and Prioritisation (IMAP) framework to accelerate the assessment of risks posed to human health and the environment by unassessed chemicals listed on the Australian Inventory of Chemical Substances (AICS). IMAP is a scientific and risk-based model for assessing chemicals with three tiers of assessment.

    Related Documents
  • 9-October-2017

    English

    Test No. 405: Acute Eye Irritation/Corrosion

    This method provides information on health hazard likely to arise from exposure to test substance (liquids, solids and aerosols) by application on the eye. This Test Guideline is intended preferably for use with albino rabbit. The test substance is applied in a single dose in the conjunctival sac of one eye of each animal. The other eye, which remains untreated, serves as a control. The initial test uses an animal; the dose level depends on the test substance nature. A confirmatory test should be made if a corrosive effect is not observed in the initial test, the irritant or negative response should be confirmed using up to two additional animals. It is recommended that it be conducted in a sequential manner in one animal at a time, rather than exposing the two additional animals simultaneously. The duration of the observation period should be sufficient to evaluate fully the magnitude and reversibility of the effects observed. The eyes should be examined at 1, 24, 48, and 72 hours after test substance application. The ocular irritation scores should be evaluated in conjunction with the nature and severity of lesions, and their reversibility or lack of reversibility. Use of topical anesthetics and systemic analgesics to avoid or minimize pain and distress in ocular safety testing procedures is described.
  • << < 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 > >>